Arimidex News
AstraZeneca's breast cancer drug gets 6-month extension from US ... - Hemscott
The British and Swedish drugmaker said sales of Arimidex were 507 mln stg in the first nine months of 2007, a 15 pct rise from the first nine months of 2006 ...
AstraZeneca: FDA extends cancer drug patent by six months - Reuters.uk
N: Quote, Profile , Research) said US health regulators extended market exclusivity for its breast cancer drug, Arimidex, by six months. ...
Food and Drug Administration grants six-month extension to ... - CNNMoney.com
based pharmaceutical company said sales of Arimidex were $507 million in the first nine months of 2007, a 15% rise from the first nine months of 2006.
astrazeneca’s Breast Cancer Drug Exclusivity in the US Prolonged ... - Genetic Engineering News (press release)
FDA extended the exclusivity period for astrazeneca’s breast cancer drug Arimidex® by granting a six-month pediatric exclusivity. Yet, the firm says that it ...
astrazeneca: Drug Exclusivity Extended - CNNMoney.com
Arimidex is currently approved in the US for various breast cancer-related uses in adult women. The FDA granted astrazeneca an additional six months of ...
FDA Grants Six Months Pediatric Exclusivity For astrazeneca's Arimidex - Trading Markets (press release)
Earlier, the patent for Arimidex was due to expire in December 2009. Arimidex is currently approved in the US for the adjuvant treatment of postmenopausal ...
AstraZeneca Receives Six Months Pediatric Exclusivity Patent ... - CNNMoney.com
Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX (granted in ...
astrazeneca profit deteriorates - The Local
The group is meanwhile known for producing the cholesterol treatment Crestor and breast cancer medicine Arimidex. But last month astrazeneca lost its ...
Market Report -- In Play (AZN) - MSN Money
astrazeneca announces it receives six months pediatric exclusivity patent extension for ARIMIDEX from the FDA Co announces that the FDA has granted an ...
Market Report -- In Play (AZN) - MSN Money
astrazeneca announces it receives six months pediatric exclusivity patent extension for ARIMIDEX from the FDA Co announces that the FDA has granted an ...
Arimidex RSS Feed